Liposomes are essentially a subtype of nanoparticles comprising a hydrophobic tail and a
hydrophilic head constituting a phospholipid membrane. The spherical or multilayered …

Cubosomes are highly stable nanoparticles formed from the lipid cubic phase and stabilized
by a polymer based outer corona. Bicontinuous lipid cubic phases consist of a single lipid …

Nanoparticle/microparticle‐based drug delivery systems for systemic (ie, intravenous)
applications have significant advantages over their nonformulated and free drug …

ABSTRACT A commonly held view is that nanocarriers conjugated to polyethylene glycol
(PEG) are non-immunogenic. However, many studies have reported that unexpected …

Nanotechnology in medical applications, especially in oncology as drug delivery systems,
has recently shown promising results. However, although these advances have been …

The innate immune system provides the first line of defence against foreign microbes and
particulate materials. Engineered nanoparticles can interact with the immune system in …

Mortality from coronavirus disease 2019 (COVID-19) in populations at high risk, such as the
elderly, certain ethnic groups (eg, Black/African American, and Hispanic/Latino persons) …

The propensity of the hepatic macrophages (Kupffer cells) to rapidly intercept particulate
materials from the blood has been frustrating in redirecting intravenously injected …

Liposomes are the first and mostly explored nanocarriers for cancer drug delivery, which
have shown great promise in clinical applications, but their limited accumulation and …

The use of lipid nanocarriers for drug delivery applications is an active research area, and a
great interest has particularly been shown in the past two decades. Among different lipid …